After 18 years in development, AstraZeneca’s CTLA-4 antibody gets the red carpet treatment at the FDA – Endpoints News April 25, 2022 by Health Topic Contributor After 18 years in development, AstraZeneca’s CTLA-4 antibody gets the red carpet treatment at the FDA Endpoints News >View original article Contributor: